T CELL SCIENCES FORM 10-K

Company

Celldex Therapeutics, Inc.

Filed

March 26, 1997

Period of Report

December 31, 1996

Accession Number

0001029869-97-000366

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →